Jul 01,2020

NICE Partners with Flatiron Health to Develop Real-World Evidence Research Methodologies

The National Institute for Health and Care Excellence (NICE) is partnering with Flatiron Health, an oncology research and technology company, to explore how real-world evidence (RWE) can inform the clinical and cost effectiveness of health technologies. Flatiron Health and NICE experts will together conduct research that leverages Flatiron expertise and evidence generated from Flatiron’s electronic-health-record (EHR)-derived database; no individual patient data will be shared. An initial research project already underway will compare survival estimates from clinical trials to survival data observed in actual patient records to evaluate opportunities to reduce uncertainty in the estimation of long-term outcomes.

COLLABORATION PARTNERSHIP

#r&d

#rwe

#rwd

View Analyst & Ambassador Comments
Go to original news
Aug 30,2020

Billings Clinic selects Carevive as a partner for remote monitoring of cancer treatment symptoms and delivery of leading-edge virtual care

Carevive was selected by Billings for the evidence-based content embedded in its oncology platform and the depth of integration with the Cerner EHR. By partnering with Carevive and Cerner for remote symptom monitoring, Billings can virtually manage symptoms for remote patients on active treatment and reduce avoidable ED visits and hospitalizations.

COLLABORATION PARTNERSHIP

#institution

#rpm

#platform

View Analyst & Ambassador Comments
Go to original news
Aug 28,2020

St. John’s Health Selects Carevive To Increase Care Coordination with Huntsman Cancer Institute

St. John’s Health, a community hospital in Jackson Hole, Wyoming, announced its partnership with Carevive, to provide care plans and home-based symptom monitoring for patients being treated for cancer. St. John’s is an affiliate of the NCI-designated cancer research facility and hospital, Huntsman Cancer Institute – University of Utah. After diagnosis, patients local to Jackson Hole often choose to be treated at St. John’s Health, approximately five hours away from Huntsman in Salt Lake City. With Carevive, St. John’s can electronically share patient treatment plans, care plans and patient experience insights on active treatment with Huntsman’s oncologists to improve care coordination.

COLLABORATION PARTNERSHIP

#institution

#rpm

#platform

View Analyst & Ambassador Comments
Go to original news
Aug 22,2020

Patient and clinician perspectives of desired features for a web-based self-management program (icanmanage.ca): exposing patients “hard work” of managing acute cancer

People with cancer benefit from self-management support, but report limitations in the type/amount of support they receive from healthcare professionals during cancer treatment. To intervene in this critical period, our team is developing a web-based self-management system, called I Can Manage Cancer (ICMC). The purpose of this paper is to report patient and clinician perspectives on the preferred features and functions in a self-management system that informed the development of the ICMC program.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Aug 28,2020

A COVID-19 screening tool for oncology telephone triage

Symptoms associated with COVID-19 infection have made the assessment and triage of cancer patients extremely complicated. The purpose of this paper is to describe the development and implementation of a COVID-19 screening tool for oncology telephone triage.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Aug 07,2020

By Next Year, Will Doctors Finally Have The Technology To Fully Personalize Treatments For Lung Cancer Patients?

OncoHost, an Israeli precision oncology company is now in the final steps of finalizing a host response profiling platform for predicting patient response to cancer therapeutics. The company’s technology is based on high-throughput protein analysis, machine-learning algorithms, and bioinformatics tools. Its product, PROphetTM, is currently under study in a multi-center international clinical trial to predict patient response to immune-checkpoint inhibitors for non-small cell lung cancer and melanoma.

PRODUCT

#platform

View Analyst & Ambassador Comments
Go to original news
Sep 14,2020

Kaiku Health to present research at ESMO 2020

Kaiku Health will present two scientific abstracts at the ESMO Virtual Congress 2020. The research has been conducted in collaboration with Oulu University Hospital and it investigates combining machine learning, patient-reported symptom data and lab measurements to analyse treatment response and predict the onset of immune-related adverse events in immune checkpoint inhibitor therapies. The posters will be presented at the ESMO Virtual Congress 2020 from September 17th to September 21st on the Congress platform.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Sep 09,2020

SkinVision partners with leading Australian sun protective clothing brand Solbari

Solbari and SkinVision have joined forces to support the fight against Skin Cancer. This partnership will see Solbari complementing their own products with at-home SkinVision Skin Checks, increasing skin cancer awareness and early detection. They will empower their global customer base to perform remote checks for signs of the disease by providing access to SkinVision.

COLLABORATION PARTNERSHIP

#product & service

View Analyst & Ambassador Comments
Go to original news
Sep 25,2020

2020 ESMO Recap: Oncology Community Unites to Bring Innovation to Patients With Cancer

The European Society for Medical Oncology (ESMO) recently hosted its annual congress, remaining dedicated to supporting oncology professionals to ensure patients with cancer are receiving the best possible care despite the challenges of converting to a virtual meeting due to coronavirus disease 2019 (COVID-19).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Sep 10,2020

OncoHealth Launches Pharmacy Consulting Services

Through OncoHealth’s Pharmacy Consulting Services, health plans can leverage a team of board-certified oncology pharmacists and board-certified medical oncologists and hematologists to keep current on the rapidly changing cancer therapy landscape. Through this increased awareness, health plans can improve cancer care for their members and develop more cost-effective approaches to high-quality care.

PRODUCT

#platform

View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY